Chemours (CC) PT Lowered to $20 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Chemours (CC) Misses Q4 EPS by 1c ; Provides Outlook
February 18, 2025 6:03 AM ESTChemours (NYSE: CC) reported Q4 EPS of $0.11, $0.01 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.37 billion.
Full Year 2025 Outlook
The Company expects to deliver 2025 Adjusted EBITDA of $825 million... More
